Page 3 - Sartorius News Today

Picks-and-shovel healthcare companies like Danaher and Repligen that supply drugmakers are seeing a slowdown

Press Release Göttingen, May 4, 2023 Sartorius announces CFO transition ... | May 4, 2023

The champion hoop will make a call on his future, with many tipping him to stay in Hong Kong, where he has been the dominant rider for the best part of a decade.

PRESS RELEASE Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry va-Q-tec and Sartorius are... | April 27, 2023

Australia's champion rider will be seeking back-to-back G1 wins at Royal Ascot

Sartorius shares continued their downward slide on Friday. At 332 euros at times, they reached their lowest level since the beginning of November. As on the previous day, they were in last place on... | April 21, 2023

After the Covid-19-related business and inventory buildup by customers had triggered strong additional growth momentum in previous years, demand normalization at the life science group Sartorius c ...

DJ Sartorius Stedim Biotech SA: First-quarter results 2023 of Sartorius Stedim Biotech Sartorius Stedim Biotech SA / Key word(s): Quarter Results Sartorius Stedim Biotech SA: First-quarter results

Sartorius Stedim Biotech SA / Key word(s): Quarter Results Sartorius Stedim Biotech SA: First-quarter results 2023 of Sartorius Stedim Biotech 20-Apr-2023 / 07:00 CET/CEST Aubagne, France, April 20, 2023 First-quarter results 2023 of Sartorius Stedim Biotech   Sales revenue of 726 million euros,...

U.S. bank JPMorgan left its rating for Sartorius at Overweight with a price target of 530 euros after first-quarter figures. The surprisingly weak start to the year and the surprisingly sluggish order... | April 20, 2023